市場調査レポート

商品コード

1734883

乳酸菌株市場の2032年までの予測：タイプ別、形態別、エンドユーザー別、地域別の世界分析

Lactobacillus Strains Market Forecasts to 2032 - Global Analysis By Type, Form, End User and By Geography

出版日: 2025年05月03日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 597,932円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 756,420円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 914,908円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,080,600円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.08円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の乳酸菌株市場は予測期間中にCAGR7.2％で成長しています。

乳酸菌株は善玉菌の一種で、ケフィア、ザワークラウト、ヨーグルトなどの発酵食品や人間の腸内で頻繁に見られます。免疫系を強化し、危険な病原体の増殖を防ぎ、腸内細菌叢のバランスをとることで、これらのプロバイオティクス微生物は消化器系の健康を維持するために不可欠です。ラクトバチルスアシドフィルス、ラクトバチルスラムノサス、ラクトバチルスカゼイなど、さまざまな菌株は、免疫機能を全体的にサポートし、乳糖の消化を改善し、胃腸の不快感を軽減するなどの健康上の利点を持つ特別な性質を持っています。さらに、腸の健康を促進し、特定の感染症を予防する治療的可能性から、栄養補助食品や機能性食品への利用がますます検討されています。

米国国立衛生研究所（NIH）のデータによると、プロバイオティクスは実に約390万人（成人人口の1.6％）が健康維持の一環として利用しています。乳酸菌株は、最も一般的に摂取されているプロバイオティクスのひとつです。

消費者の腸の健康に対する意識の高まり

健康全般を維持する上で腸内細菌叢が健康であることの重要性は、消費者に広く認識されつつあります。プロバイオティクスが免疫調整と消化器系のバランスに極めて重要であることを提唱する科学論文、健康インフルエンサー、医療専門家らが、こうした認識を後押ししています。特に乳酸菌株は、下痢の予防、栄養吸収の促進、腹部膨満感の軽減といった利点が確立されているため、人気を博しています。さらに、こうしたプロバイオティクスは、サプリメントや機能性食品を通じて人々の日々の食生活に積極的に取り入れられており、これが国際市場での安定した需要を牽引しています。

菌株別規制と標準化の不在

多くのプロバイオティクス製品が乳酸菌株含有を謳っているにもかかわらず、表示、効能、効果には一貫性がないことが多いです。規制の枠組みには地域差が大きく、すべての国が特定の菌株に関する健康強調表示の臨床的検証を義務付けているわけではありません。このため、プロバイオティクスの基準が世界的に統一されず、消費者が混乱する原因となっています。さらに、菌株固有の用途に必要な識別や用量のガイドラインがない場合、消費者の信頼が損なわれ、科学的に進歩した製剤の商業化が制限される可能性があります。

プロバイオティクス物質の創出

医薬品グレードのプロバイオティクスの創製への投資は増加しており、乳酸菌株は栄養補助食品だけでなく、治療の補助食品としても販売されています。細菌性膣炎、炎症性腸疾患（IBD）、抗生物質関連下痢などの治療がそのひとつです。さらに、処方用プロバイオティクスの出現と菌株特異的効果を確認する臨床研究により、乳酸菌株の治療可能性の活用を期待する製薬企業やバイオテクノロジー企業に新たな収益源が開かれています。

高い価格圧力と市場競争

世界企業からローカルサプリメントブランドまで、多くのプレーヤーの導入により、乳酸菌株を含むプロバイオティクス市場は極めて競争の激しいものとなっています。その結果、特に機能性食品や栄養補助食品業界では価格競争が起きています。ブランドが品質や革新性ではなく価格で競争することで起こるコモディティ化によって、菌株固有の効能が持つ独特の価値が低下する可能性があります。さらに、小売チェーンにおけるプライベートブランド商品は、プレミアムメーカーの価格決定力をさらに弱め、長期的な存続可能性と収益性を低下させます。

COVID-19の影響：

COVID-19の大流行は、乳酸菌株市場に様々な影響を与えました。乳酸菌株を含むプロバイオティクスサプリメントや機能性食品は、免疫や腸の健康に対する消費者の意識が大幅に高まった結果、高い需要があります。パンデミックの間、サプリメントを摂取するアメリカ人の43％以上が免疫サポート製品の消費を増やし、短期的な売上を伸ばしました。しかし、市場はサプライチェーンの混乱、原材料へのアクセス制限、特に冷蔵保存されるプロバイオティクス製品の生産・流通の遅れといった問題とも戦う必要がありました。さらに、製品承認や臨床試験は規制の遅れに影響され、イノベーションをやや阻害しました。

予測期間中、乳酸菌セグメントが最大となる見込み

予測期間中、乳酸菌セグメントが最大の市場シェアを占めると予想されます。この優位性は、免疫力強化、腸の健康促進、乳糖消化促進などの利点が証明されているため、医薬品、発酵乳製品、栄養補助食品に幅広く使用されていることに起因しています。最も研究されているプロバイオティクス菌株のひとつがラクトバチルスアシドフィルスで、これは多系統の製剤によく含まれ、その安定性と他の善玉菌との相性の良さで知られています。さらに、ラクトバチルスアシドフィルスの強力な臨床検証と適応性は、既存市場および新興国市場の両方のプロバイオティクス市場における持続的優位性を保証しています。

予測期間中、液体分野が最も高いCAGRが見込まれる

予測期間中、液体分野が最も高い成長率を示すと予測されます。この拡大は、飲みやすく効率的なプロバイオティクスサプリメントに対するニーズの高まりによるところが大きいです。生物学的利用能の向上と摂取のしやすさから、液体製剤は特に高齢者や子供に好まれています。また、液体製剤は動物飼料にも頻繁に使用されており、市場の急成長を説明する一助となっています。さらに、消費者の選好がより入手しやすく強力なプロバイオティクスの選択肢へと変化するにつれて、液体市場は大きく成長すると予想されます。

最大シェアの地域：

予測期間中、アジア太平洋が最大の市場シェアを占めると予想されます。発酵食品の豊かな文化的遺産、健康意識の高まり、中国やインドのような国の急速な人口拡大など、数多くの要因がこのリーダーシップに寄与しています。ケフィア、キムチ、ヨーグルトのようなプロバイオティクスが豊富な食品の人気の高まりや、腸の健康に対する利点に対する意識の高まりにより、乳酸菌ベースの製品に対する需要が大幅に増加しています。さらに、アジア太平洋の現地生産者が最先端のプロバイオティクス製剤を発売してこの動向を活用しているため、アジア太平洋が市場拡大の大きな力となっています。

CAGRが最も高い地域：

予測期間中、北米地域が最も高いCAGRを示すと予想されますが、これは健康志向の消費者の増加と免疫と腸の健康の利点に関する知識の高まりが原動力となっています。機能性食品に対する需要は、特に予防的なウェルネスを求めるミレニアル世代や高齢者層の間で大幅に増加しており、これがこの成長の原動力となっています。さらに、乳酸菌株の市場成長は、この地域の強力な医療制度と有利な規制環境によってさらに支えられています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレーヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東・アフリカ

第9章主な発展

契約、パートナーシップ、コラボレーション、ジョイントベンチャー
買収と合併
新製品発売
事業拡大
その他の主要戦略

第10章企業プロファイリング

Morinaga Milk Industry Co., Ltd.
Chr. Hansen Holding A/S
Danone S.A
ADM（Archer-Daniels-Midland Company）
Nestle S.A
Koninklijke DSM N.V.
International Flavors & Fragrances Inc.
Arla Foods Inc
Lallemand Inc.
Yakult Honsha Co., Ltd.
DowDuPont
Chobani LLC
Kerry Inc
Post Holdings Inc
Novozymes Inc

図表

List of Tables

Table 1 Global Lactobacillus Strains Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Lactobacillus Strains Market Outlook, By Type (2024-2032) ($MN)
Table 3 Global Lactobacillus Strains Market Outlook, By Lactobacillus Acidophilus (2024-2032) ($MN)
Table 4 Global Lactobacillus Strains Market Outlook, By Lactobacillus Casei (2024-2032) ($MN)
Table 5 Global Lactobacillus Strains Market Outlook, By Lactobacillus Plantarum (2024-2032) ($MN)
Table 6 Global Lactobacillus Strains Market Outlook, By Lactobacillus Rhamnosus (2024-2032) ($MN)
Table 7 Global Lactobacillus Strains Market Outlook, By Other Types (2024-2032) ($MN)
Table 8 Global Lactobacillus Strains Market Outlook, By Form (2024-2032) ($MN)
Table 9 Global Lactobacillus Strains Market Outlook, By Powder (2024-2032) ($MN)
Table 10 Global Lactobacillus Strains Market Outlook, By Capsules (2024-2032) ($MN)
Table 11 Global Lactobacillus Strains Market Outlook, By Liquid (2024-2032) ($MN)
Table 12 Global Lactobacillus Strains Market Outlook, By Freeze-dried (2024-2032) ($MN)
Table 13 Global Lactobacillus Strains Market Outlook, By Tablets (2024-2032) ($MN)
Table 14 Global Lactobacillus Strains Market Outlook, By End User (2024-2032) ($MN)
Table 15 Global Lactobacillus Strains Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
Table 16 Global Lactobacillus Strains Market Outlook, By Dairy Beverages (2024-2032) ($MN)
Table 17 Global Lactobacillus Strains Market Outlook, By Non-dairy Beverages (2024-2032) ($MN)
Table 18 Global Lactobacillus Strains Market Outlook, By Infant Formula (2024-2032) ($MN)
Table 19 Global Lactobacillus Strains Market Outlook, By Other End Users (2024-2032) ($MN)
Table 20 North America Lactobacillus Strains Market Outlook, By Country (2024-2032) ($MN)
Table 21 North America Lactobacillus Strains Market Outlook, By Type (2024-2032) ($MN)
Table 22 North America Lactobacillus Strains Market Outlook, By Lactobacillus Acidophilus (2024-2032) ($MN)
Table 23 North America Lactobacillus Strains Market Outlook, By Lactobacillus Casei (2024-2032) ($MN)
Table 24 North America Lactobacillus Strains Market Outlook, By Lactobacillus Plantarum (2024-2032) ($MN)
Table 25 North America Lactobacillus Strains Market Outlook, By Lactobacillus Rhamnosus (2024-2032) ($MN)
Table 26 North America Lactobacillus Strains Market Outlook, By Other Types (2024-2032) ($MN)
Table 27 North America Lactobacillus Strains Market Outlook, By Form (2024-2032) ($MN)
Table 28 North America Lactobacillus Strains Market Outlook, By Powder (2024-2032) ($MN)
Table 29 North America Lactobacillus Strains Market Outlook, By Capsules (2024-2032) ($MN)
Table 30 North America Lactobacillus Strains Market Outlook, By Liquid (2024-2032) ($MN)
Table 31 North America Lactobacillus Strains Market Outlook, By Freeze-dried (2024-2032) ($MN)
Table 32 North America Lactobacillus Strains Market Outlook, By Tablets (2024-2032) ($MN)
Table 33 North America Lactobacillus Strains Market Outlook, By End User (2024-2032) ($MN)
Table 34 North America Lactobacillus Strains Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
Table 35 North America Lactobacillus Strains Market Outlook, By Dairy Beverages (2024-2032) ($MN)
Table 36 North America Lactobacillus Strains Market Outlook, By Non-dairy Beverages (2024-2032) ($MN)
Table 37 North America Lactobacillus Strains Market Outlook, By Infant Formula (2024-2032) ($MN)
Table 38 North America Lactobacillus Strains Market Outlook, By Other End Users (2024-2032) ($MN)
Table 39 Europe Lactobacillus Strains Market Outlook, By Country (2024-2032) ($MN)
Table 40 Europe Lactobacillus Strains Market Outlook, By Type (2024-2032) ($MN)
Table 41 Europe Lactobacillus Strains Market Outlook, By Lactobacillus Acidophilus (2024-2032) ($MN)
Table 42 Europe Lactobacillus Strains Market Outlook, By Lactobacillus Casei (2024-2032) ($MN)
Table 43 Europe Lactobacillus Strains Market Outlook, By Lactobacillus Plantarum (2024-2032) ($MN)
Table 44 Europe Lactobacillus Strains Market Outlook, By Lactobacillus Rhamnosus (2024-2032) ($MN)
Table 45 Europe Lactobacillus Strains Market Outlook, By Other Types (2024-2032) ($MN)
Table 46 Europe Lactobacillus Strains Market Outlook, By Form (2024-2032) ($MN)
Table 47 Europe Lactobacillus Strains Market Outlook, By Powder (2024-2032) ($MN)
Table 48 Europe Lactobacillus Strains Market Outlook, By Capsules (2024-2032) ($MN)
Table 49 Europe Lactobacillus Strains Market Outlook, By Liquid (2024-2032) ($MN)
Table 50 Europe Lactobacillus Strains Market Outlook, By Freeze-dried (2024-2032) ($MN)
Table 51 Europe Lactobacillus Strains Market Outlook, By Tablets (2024-2032) ($MN)
Table 52 Europe Lactobacillus Strains Market Outlook, By End User (2024-2032) ($MN)
Table 53 Europe Lactobacillus Strains Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
Table 54 Europe Lactobacillus Strains Market Outlook, By Dairy Beverages (2024-2032) ($MN)
Table 55 Europe Lactobacillus Strains Market Outlook, By Non-dairy Beverages (2024-2032) ($MN)
Table 56 Europe Lactobacillus Strains Market Outlook, By Infant Formula (2024-2032) ($MN)
Table 57 Europe Lactobacillus Strains Market Outlook, By Other End Users (2024-2032) ($MN)
Table 58 Asia Pacific Lactobacillus Strains Market Outlook, By Country (2024-2032) ($MN)
Table 59 Asia Pacific Lactobacillus Strains Market Outlook, By Type (2024-2032) ($MN)
Table 60 Asia Pacific Lactobacillus Strains Market Outlook, By Lactobacillus Acidophilus (2024-2032) ($MN)
Table 61 Asia Pacific Lactobacillus Strains Market Outlook, By Lactobacillus Casei (2024-2032) ($MN)
Table 62 Asia Pacific Lactobacillus Strains Market Outlook, By Lactobacillus Plantarum (2024-2032) ($MN)
Table 63 Asia Pacific Lactobacillus Strains Market Outlook, By Lactobacillus Rhamnosus (2024-2032) ($MN)
Table 64 Asia Pacific Lactobacillus Strains Market Outlook, By Other Types (2024-2032) ($MN)
Table 65 Asia Pacific Lactobacillus Strains Market Outlook, By Form (2024-2032) ($MN)
Table 66 Asia Pacific Lactobacillus Strains Market Outlook, By Powder (2024-2032) ($MN)
Table 67 Asia Pacific Lactobacillus Strains Market Outlook, By Capsules (2024-2032) ($MN)
Table 68 Asia Pacific Lactobacillus Strains Market Outlook, By Liquid (2024-2032) ($MN)
Table 69 Asia Pacific Lactobacillus Strains Market Outlook, By Freeze-dried (2024-2032) ($MN)
Table 70 Asia Pacific Lactobacillus Strains Market Outlook, By Tablets (2024-2032) ($MN)
Table 71 Asia Pacific Lactobacillus Strains Market Outlook, By End User (2024-2032) ($MN)
Table 72 Asia Pacific Lactobacillus Strains Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
Table 73 Asia Pacific Lactobacillus Strains Market Outlook, By Dairy Beverages (2024-2032) ($MN)
Table 74 Asia Pacific Lactobacillus Strains Market Outlook, By Non-dairy Beverages (2024-2032) ($MN)
Table 75 Asia Pacific Lactobacillus Strains Market Outlook, By Infant Formula (2024-2032) ($MN)
Table 76 Asia Pacific Lactobacillus Strains Market Outlook, By Other End Users (2024-2032) ($MN)
Table 77 South America Lactobacillus Strains Market Outlook, By Country (2024-2032) ($MN)
Table 78 South America Lactobacillus Strains Market Outlook, By Type (2024-2032) ($MN)
Table 79 South America Lactobacillus Strains Market Outlook, By Lactobacillus Acidophilus (2024-2032) ($MN)
Table 80 South America Lactobacillus Strains Market Outlook, By Lactobacillus Casei (2024-2032) ($MN)
Table 81 South America Lactobacillus Strains Market Outlook, By Lactobacillus Plantarum (2024-2032) ($MN)
Table 82 South America Lactobacillus Strains Market Outlook, By Lactobacillus Rhamnosus (2024-2032) ($MN)
Table 83 South America Lactobacillus Strains Market Outlook, By Other Types (2024-2032) ($MN)
Table 84 South America Lactobacillus Strains Market Outlook, By Form (2024-2032) ($MN)
Table 85 South America Lactobacillus Strains Market Outlook, By Powder (2024-2032) ($MN)
Table 86 South America Lactobacillus Strains Market Outlook, By Capsules (2024-2032) ($MN)
Table 87 South America Lactobacillus Strains Market Outlook, By Liquid (2024-2032) ($MN)
Table 88 South America Lactobacillus Strains Market Outlook, By Freeze-dried (2024-2032) ($MN)
Table 89 South America Lactobacillus Strains Market Outlook, By Tablets (2024-2032) ($MN)
Table 90 South America Lactobacillus Strains Market Outlook, By End User (2024-2032) ($MN)
Table 91 South America Lactobacillus Strains Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
Table 92 South America Lactobacillus Strains Market Outlook, By Dairy Beverages (2024-2032) ($MN)
Table 93 South America Lactobacillus Strains Market Outlook, By Non-dairy Beverages (2024-2032) ($MN)
Table 94 South America Lactobacillus Strains Market Outlook, By Infant Formula (2024-2032) ($MN)
Table 95 South America Lactobacillus Strains Market Outlook, By Other End Users (2024-2032) ($MN)
Table 96 Middle East & Africa Lactobacillus Strains Market Outlook, By Country (2024-2032) ($MN)
Table 97 Middle East & Africa Lactobacillus Strains Market Outlook, By Type (2024-2032) ($MN)
Table 98 Middle East & Africa Lactobacillus Strains Market Outlook, By Lactobacillus Acidophilus (2024-2032) ($MN)
Table 99 Middle East & Africa Lactobacillus Strains Market Outlook, By Lactobacillus Casei (2024-2032) ($MN)
Table 100 Middle East & Africa Lactobacillus Strains Market Outlook, By Lactobacillus Plantarum (2024-2032) ($MN)
Table 101 Middle East & Africa Lactobacillus Strains Market Outlook, By Lactobacillus Rhamnosus (2024-2032) ($MN)
Table 102 Middle East & Africa Lactobacillus Strains Market Outlook, By Other Types (2024-2032) ($MN)
Table 103 Middle East & Africa Lactobacillus Strains Market Outlook, By Form (2024-2032) ($MN)
Table 104 Middle East & Africa Lactobacillus Strains Market Outlook, By Powder (2024-2032) ($MN)
Table 105 Middle East & Africa Lactobacillus Strains Market Outlook, By Capsules (2024-2032) ($MN)
Table 106 Middle East & Africa Lactobacillus Strains Market Outlook, By Liquid (2024-2032) ($MN)
Table 107 Middle East & Africa Lactobacillus Strains Market Outlook, By Freeze-dried (2024-2032) ($MN)
Table 108 Middle East & Africa Lactobacillus Strains Market Outlook, By Tablets (2024-2032) ($MN)
Table 109 Middle East & Africa Lactobacillus Strains Market Outlook, By End User (2024-2032) ($MN)
Table 110 Middle East & Africa Lactobacillus Strains Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
Table 111 Middle East & Africa Lactobacillus Strains Market Outlook, By Dairy Beverages (2024-2032) ($MN)
Table 112 Middle East & Africa Lactobacillus Strains Market Outlook, By Non-dairy Beverages (2024-2032) ($MN)
Table 113 Middle East & Africa Lactobacillus Strains Market Outlook, By Infant Formula (2024-2032) ($MN)
Table 114 Middle East & Africa Lactobacillus Strains Market Outlook, By Other End Users (2024-2032) ($MN)

Product Code: SMRC29520

According to Stratistics MRC, the Global Lactobacillus Strains Market is growing at a CAGR of 7.2% during the forecast period. Lactobacillus strains are a type of good bacteria that are frequently found in fermented foods like kefir, sauerkraut, and yogurt as well as in the human gut. By strengthening the immune system, preventing the growth of dangerous pathogens, and balancing the gut microbiota, these probiotic microbes are essential for preserving digestive health. Different strains, including Lactobacillus acidophilus, Lactobacillus rhamnosus, and Lactobacillus casei, have special qualities that support immune function overall, improve lactose digestion, and lessen gastrointestinal discomfort, among other health benefits. Moreover, their therapeutic potential in promoting gut health and preventing certain infections has led to an increasing exploration of their use in dietary supplements and functional foods.

According to data from the National Institutes of Health (NIH), probiotics are indeed used by approximately 3.9 million U.S. adults, which account for 1.6% of the adult population, as part of their wellness routines. Lactobacillus strains are among the most commonly consumed probiotics.

Market Dynamics:

Driver:

Growing awareness of gut health among consumers

The significance of a healthy gut microbiota in preserving general wellness is becoming more widely acknowledged by consumers. Scientific publications, health influencers, and medical professionals who advocate probiotics as crucial for immune modulation and digestive balance are driving this awareness. The well-established advantages of Lactobacillus strains, in particular, like preventing diarrhea, promoting nutrient absorption, and lessening bloating, have made them popular. Moreover, these probiotics are therefore being actively added to people's daily diets through supplements and functional foods, which is driving steady demand in international markets.

Restraint:

Absence of strain-specific regulation and standardization

Despite the fact that many probiotic products make the claim to contain Lactobacillus strains, labeling, potency, and efficacy are frequently inconsistent. There are significant regional differences in regulatory frameworks, and not all nations require clinical validation for health claims pertaining to particular strains. This prevents probiotic standards from being harmonized globally and causes consumers to become confused. Furthermore, if strain-specific applications lack required identification and dosage guidelines, consumer confidence may be damaged, and the commercialization of scientifically advanced formulations may be restricted.

Opportunity:

Creation of probiotic substances

Investment in the creation of pharmaceutical-grade probiotics is rising, and Lactobacillus strains are being marketed as supplements to medical treatments as well as dietary supplements. Treatments for bacterial vaginosis, inflammatory bowel disease (IBD), antibiotic-associated diarrhea, and other conditions are among them. Moreover, the emergence of prescription probiotics and clinical studies confirming strain-specific effects opens up new revenue streams for pharmaceutical and biotech companies hoping to leverage Lactobacillus strains' therapeutic potential.

Threat:

High levels of price pressure and market competition

The introduction of many players, from global firms to local supplement brands, has made the probiotic market-which includes Lactobacillus strains-extremely competitive. There are now price wars as a result, especially in the functional food and dietary supplement industries. The distinctive value of strain-specific benefits may be diminished as a result of commoditization, which occurs when brands compete on price rather than quality or innovation. Furthermore, private-label goods in retail chains further weaken premium manufacturers' pricing power, reducing their long-term viability and profitability.

Covid-19 Impact:

The COVID-19 pandemic affected the market for Lactobacillus strains in a variety of ways. Probiotic supplements and functional foods that contain Lactobacillus strains are in high demand as a result of the substantial increase in consumer awareness of immunity and gut health. During the pandemic, more than 43 percent of Americans who take supplements increased their consumption of immune-supporting products, which increased short-term sales. But the market also had to contend with issues like disruptions in the supply chain, restricted access to raw materials, and production and distribution delays, especially for probiotic products that were refrigerated. Additionally, product approvals and clinical trials were impacted by regulatory slowdowns, which somewhat inhibited innovation.

The lactobacillus acidophilus segment is expected to be the largest during the forecast period

The lactobacillus acidophilus segment is expected to account for the largest market share during the forecast period. This dominance is ascribed to its extensive use in pharmaceuticals, fermented dairy products, and dietary supplements because of its proven advantages in enhancing immunity, promoting gut health, and facilitating lactose digestion. One of the most studied probiotic strains is Lactobacillus acidophilus, which is frequently found in multistrain formulations and is known for its stability and compatibility with other good bacteria. Moreover, Lactobacillus acidophilus's strong clinical validation and adaptability guarantee its sustained dominance in both established and developing probiotic markets.

The liquid segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the liquid segment is predicted to witness the highest growth rate. This expansion is mostly due to the growing need for easy-to-take and efficient probiotic supplements. Due to their improved bioavailability and ease of consumption, liquid formulations are especially well-liked by older adults and children. The liquid form is also frequently used in animal feed, which helps explain its quick market growth. Additionally, the liquid market is expected to grow significantly as consumer preferences change toward more readily available and powerful probiotic options, which will be in line with larger trends in health and wellness.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share. Numerous factors, such as a rich cultural legacy of fermented foods, increased health consciousness, and a rapidly expanding population in nations like China and India, are contributing to this leadership. The demand for Lactobacillus-based products has increased significantly as a result of the growing popularity of probiotic-rich foods like kefir, kimchi, and yogurt as well as growing awareness of the advantages for gut health. Furthermore, Asia Pacific is becoming a major force behind market expansion as local producers in the area are leveraging this trend by launching cutting-edge probiotic formulations.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by a rise in health-conscious consumers and growing knowledge of the advantages of immunity and gut health. The demand for functional foods has significantly increased, especially among millennials and older populations looking for preventive wellness options, which is driving this growth. Moreover, the market growth for Lactobacillus strains is further supported by the region's strong healthcare system and advantageous regulatory environment.

Key players in the market

Some of the key players in Lactobacillus Strains Market include Morinaga Milk Industry Co., Ltd., Chr. Hansen Holding A/S, Danone S.A, ADM (Archer-Daniels-Midland Company), Nestle S.A, Koninklijke DSM N.V., International Flavors & Fragrances Inc., Arla Foods Inc, Lallemand Inc., Yakult Honsha Co., Ltd., DowDuPont, Chobani LLC, Kerry Inc, Post Holdings Inc and Novozymes Inc.

Key Developments:

In September 2024, Nestle is to build its first food factory in Saudi Arabia after signing a contract commiting to the project. The Saudi Press Agency, the country's state news agency, reported that Nestle has signed up for a 117,000 sq m plot in Jeddah's Third Industrial City.

In January 2024, French food group Danone said that it had signed an agreement to sell its premium organic dairy units in the United States to investment firm Platinum Equity. The sale of the Horizon Organic and Wallaby businesses is part of the company's portfolio review and asset rotation program the company announced in March 2022, Danone said in a statement, without disclosing the financial details of the deal.

In December 2023, Kerry Group plc announces it has entered into a definitive agreement to acquire part of the global lactase enzyme business of Chr. Hansen Holding A/S and Novozymes A/S on a carve out basis. This acquisition is subject to European Commission approval of Kerry as a buyer and forms part of the Novozymes and Chr. Hansen merger approval process.

Types Covered:

Lactobacillus Acidophilus
Lactobacillus Casei
Lactobacillus Plantarum
Lactobacillus Rhamnosus
Other Types

Forms Covered:

Powder
Capsules
Liquid
Freeze-dried
Tablets

End Users Covered:

Functional Food & Beverages
Infant Formula
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Lactobacillus Strains Market, By Type

5.1 Introduction
5.2 Lactobacillus Acidophilus
5.3 Lactobacillus Casei
5.4 Lactobacillus Plantarum
5.5 Lactobacillus Rhamnosus
5.6 Other Types

6 Global Lactobacillus Strains Market, By Form

6.1 Introduction
6.2 Powder
6.3 Capsules
6.4 Liquid
6.5 Freeze-dried
6.6 Tablets

7 Global Lactobacillus Strains Market, By End User

7.1 Introduction
7.2 Functional Food & Beverages
- 7.2.1 Dairy Beverages
- 7.2.2 Non-dairy Beverages
7.3 Infant Formula
7.4 Other End Users

8 Global Lactobacillus Strains Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 Morinaga Milk Industry Co., Ltd.
10.2 Chr. Hansen Holding A/S
10.3 Danone S.A
10.4 ADM (Archer-Daniels-Midland Company)
10.5 Nestle S.A
10.6 Koninklijke DSM N.V.
10.7 International Flavors & Fragrances Inc.
10.8 Arla Foods Inc
10.9 Lallemand Inc.
10.10 Yakult Honsha Co., Ltd.
10.11 DowDuPont
10.12 Chobani LLC
10.13 Kerry Inc
10.14 Post Holdings Inc
10.15 Novozymes Inc

乳酸菌株市場の2032年までの予測：タイプ別、形態別、エンドユーザー別、地域別の世界分析

Lactobacillus Strains Market Forecasts to 2032 - Global Analysis By Type, Form, End User and By Geography

COVID-19の影響：

最大シェアの地域：

CAGRが最も高い地域：

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の乳酸菌株市場：タイプ別

第6章 世界の乳酸菌株市場：形態別

第7章 世界の乳酸菌株市場：エンドユーザー別

第8章 世界の乳酸菌株市場：地域別

第9章 主な発展

第10章 企業プロファイリング